ArticleHealthcare (Basel, Switzerland)2022
Association of Major Chronic Noncommunicable Diseases and Life Expectancy in China, 2019.
Article in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Mechanism of health literacy impact on self-management behaviors in patients with chronic disease: a self-efficacy mediated model moderated by disease duration.Frontiers in public health · 2025Article
- The association of famine exposure with healthy lifestyles at different life stages in rural older adults in China.Frontiers in public health · 2025Article
- Loss of life expectancy due to stroke and its subtypes in urban and rural areas in China, 2005-2020.Stroke and vascular neurology · 2023Article
- Nanopore Single-molecule Analysis of Biomarkers: Providing Possible Clues to Disease Diagnosis.Trends in analytical chemistry : TRAC · 2023Article
- Mortality and Years of Life Lost Due to Brain and Other Central Nervous System Cancer in Wuhan, China, from 2010 to 2019.International journal of environmental research and public health · 2023Article
- Changes in Mortality Rates of Major Chronic Diseases Among Populations Aged Over 60 Years and Their Contributions to Life Expectancy Increase - China, 2005-2020.China CDC weekly · 2022Article
- Secular Trends of Mortality and Years of Life Lost Due to Chronic Obstructive Pulmonary Disease in Wuhan, China from 2010 to 2019: Age-Period-Cohort Analysis.International journal of environmental research and public health · 2022Article
- The GABBR1/miR-19b-3p/WNT2B axis regulates insulin resistance and liver injury in diabetes with viral infection: mechanistic and therapeutic insights.Cell cycle (Georgetown, Tex.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to illustrate the association of four major chronic noncommunicable diseases (cardiovascular diseases, cancer, respiratory diseases, and diabetes) with life expectancy (LE) of Chinese residents in 2019 and to provide an evidence base for the scientific prevention and treatment of chronic diseases in China. The abbreviated life and cause-eliminated life tables were compiled according to the Jiang Qing Lang method recommended by WHO (World Health Organization) to calculate LE and cause-eliminated life expectancy (CELE) in 2019. The disease that had the greatest association with the LE of Chinese residents was cardiovascular disease (CVD), with the LE increasing by 8.13 years after removing CVD deaths. This was followed by cancer (2.68 years), respiratory diseases (0.88 years), and diabetes (0.24 years). The four major chronic noncommunicable diseases (NCDs) were the main diseases affecting the health of Chinese residents. CVD should be prevented and treated as the key disease among the chronic diseases, while women and rural people should be the major focus of health knowledge promotion. All residents should be encouraged to develop a good understanding of self-protection and of how to achieve a healthy lifestyle in order to reduce the occurrence of death and to improve their quality of life and health in general.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.